Predicting Adverse Outcomes in Neurosurgical Patients Using Machine Learning: Exploring the Impact of Liver Function Indicators - Scorecard - MDSpire

Predicting Adverse Outcomes in Neurosurgical Patients Using Machine Learning: Exploring the Impact of Liver Function Indicators

  • By

  • Yibo Fan

  • Jingyue Zhang

  • Lin Wu

  • Shuo An

  • Yingsheng Wei

  • Jian Sun

  • Ye Tian

  • Hanxu Zhang

  • April 29, 2026

  • 0 min

Share

Clinical Scorecard: Predicting Adverse Outcomes in Neurosurgical Patients Using Machine Learning: Exploring the Impact of Liver Function Indicators

At a Glance

CategoryDetail
ConditionNeurosurgical diseases including traumatic brain injury (TBI), intracerebral hemorrhage (ICH), and aneurysmal subarachnoid hemorrhage (aSAH)
Key MechanismsIntegration of neurological status (Glasgow Coma Scale) and liver function markers (AST, albumin, ALKP) reflecting the liver-brain axis influencing neurological prognosis
Target PopulationPatients aged ≥16 years hospitalized with TBI, ICH, or aSAH without pre-existing severe liver disease
Care SettingNeurosurgery department inpatient setting with access to liver function testing

Key Highlights

  • Machine learning model (CatBoost) achieved high accuracy (AUC=0.932) in predicting unfavorable functional outcomes at discharge
  • Key predictors included admission GCS score, age, and liver function markers (AST, albumin, ALKP)
  • Lower GCS, older age, higher AST and ALKP, and lower albumin levels were associated with worse prognosis

Guideline-Based Recommendations

Diagnosis

  • Assess neurological status using Glasgow Coma Scale at admission
  • Perform liver function tests including AST, albumin, and ALKP on admission for neurosurgical patients

Management

  • Incorporate liver function markers into prognostic assessment to identify patients at risk of unfavorable outcomes
  • Use machine learning models integrating neurological and hepatic parameters to guide early intervention strategies

Monitoring & Follow-up

  • Monitor liver function markers dynamically during hospitalization to detect worsening hepatic dysfunction
  • Regularly assess neurological status alongside liver function to evaluate prognosis

Risks

  • Recognize that hepatic dysfunction may exacerbate neurological deterioration via the liver-brain axis
  • Be aware that elevated AST and ALKP and hypoalbuminemia are risk factors for poor neurosurgical outcomes

Patient & Prescribing Data

Neurosurgical patients with TBI, ICH, or aSAH without severe pre-existing liver disease

Early identification of patients with abnormal liver function markers may inform tailored therapeutic approaches and improve prognosis

Clinical Best Practices

  • Integrate liver function testing into routine evaluation of neurosurgical patients
  • Utilize machine learning tools to enhance prognostic accuracy beyond traditional clinical scoring
  • Consider the liver-brain axis in the pathophysiology and management of neurosurgical conditions
  • Exclude patients with pre-existing severe liver disease when applying prognostic models based on liver function markers
  • Validate predictive models externally in multicenter cohorts before widespread clinical implementation

References

Original Source(s)

Related Content